When:
Wednesday, Jun 22, 2022 8:50a -
Thursday, Jun 23, 2022 4:00p

Where:
Online event
26 North Street
Boston, Massachusetts 02109

EventScheduled OfflineEventAttendanceMode

Admission:
$2599.0

Categories:
Lectures & Conferences

Event website:
https://go.evvnt.com/1056250-0?pid=5248

Advance Life-Changing Therapies for Adolescents and Adults With Rare Neurological Disorders


Welcome to the 1st Rare and Genetic Neurodegenerative Drug Development Summit! This trailblazing meeting will be discussing, debating and exploring pivotal rare and genetic neurodegenerative disease research making industry news headlines.


Pioneers in this exclusive industry are convening online, this June, to network and learn from experts in pharma, biotech and academia. The inaugural Rare and Genetic Neurodegenerative Drug Development Summit is hosting enriched, cross-sponsor discussions to re-shape and guide strategic and translational decision-making targeting genetically-defined populations.


URLs:

Tickets: https://go.evvnt.com/1056250-2?pid=5248

Brochure: https://go.evvnt.com/1056250-3?pid=5248


Prices:

Drug Developer Pricing - Conference Pass: USD 2099.0,

Solution Provider Pricing - Conference Pass: USD 2599.0


Speakers: Anka G. Ehrhardt, Director, Cell-Based Assays / Analytical Research and Development, Merck, Christopher Missling, President and Chief, Executive Officer, Anavex Life Sciences, David Theron, Development Director in Neurology, Servier, Eline Appelmans, Director - Neuroscience Research, Foundation for the National Institutes of Health, Eric Schaeffer, Chief Scientific Officer, Paros Bio, Erin Rosenbaugh, FNIH Project Lead, Neuroscience Research Partnerships, George Tetz, Chief Executive Officer, Human Microbiology Institute, Greg Smiley, Founder and Chief Executive Officer, Adira Foundation, Gregory Stewart, Executive Consultant, Alchemy Neuroscience, Joff Mosakawa, President, Diligentsia, Jose Palma, Medical Director - Translational Medicine - Neuroscience and Neuromuscular Disorders, Novartis, Lingzhi Zhao, Senior Director - Gene Therapy and Transnational Discovery Gene Therapy, AGTC, Maya Chopra, Director, Translational Genomic Medicine, Rosamund Stone Zander Translational Neuroscience Center, Peter Bialek, Head of Translational Biology, Triplet Therapeutics, Robert Fremeau, Chief Scientific Officer, Vyant bio, Timothy Hammond, Lab Head, Sanofi, Yan Ni, Executive Director, Biomarkers and Precision Medicine, Passage Bio

Share this event

Add to:

Reddit
22/06/2022 08:50:00 23/06/2022 16:00:00 America/New_York 1st Rare and Genetic Neurodegenerative Drug Development Summit <p>Advance Life-Changing Therapies for Adolescents and Adults With Rare Neurological Disorders</p><p><br></p><p>Welcome to the 1st Rare and Genetic Neurodegenerative Drug Development Summit! This t... The Bostonian Boston, Boston, Massachusetts 02109 false DD/MM/YYYY